SECURITIES AND EXCHANGE COMMISSION

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________________________



FORM 8-K


CURRENT REPORT


Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

________________
 


Date of Report (Date of earliest event reported):
April 21, 2006

Alpharma Inc.
 

(Exact name of registrant as specified in its charter)
 

Delaware
(State or other jurisdiction of incorporation)

1-8593
(Commission File
Number)

22-2095212
(IRS Employer Identification)
 

One Executive Drive, Fort Lee, New Jersey 07024
(Address of principal executive offices) (Zip Code)
 

Registrant's telephone number, including area code
(201) 947-7774
 
 

Not Applicable

______________________________________________
(Former name or former address, if changed since

last report)

 

 

Item 1.01. Entry Into A Material Definitive Agreement

On April 21, 2006, Alpharma AS, a wholly owned subsidiary of Alpharma Inc. (the "Company"), and A.L. Industrier ASA ("ALI") entered into an amendment to the existing Administrative Services Agreement between the parties (the "Services Agreement"), pursuant to which the Services Agreement was extended through June 30, 2006 for an additional services fee of NOK 200,000 (approximately $30,000). ALI is the beneficial owner of all the shares of the Company's Class B common stock. As a result, the Company considers all agreements between ALI and the Company (or its subsidiaries) to be material.

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 
 

ALPHARMA INC.
 

By: /s/ Robert F. Wrobel
 

Name: Robert F. Wrobel

Title: Executive Vice President and CLO

Date: April 26, 2006